These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 12871726)
1. Enhanced expression of uridine diphosphate-N-acetylglucosaminyl transferase (OGT) in a stable, tetracycline-inducible HeLa cell line using histone deacetylase inhibitors: kinetics of cytosolic OGT accumulation and nuclear translocation. Marshall S; Duong T; Wu T; Hering MA; Yada J; Higgins S; Orbus RJ; Yan ZH; Rumberger JM Anal Biochem; 2003 Aug; 319(2):304-13. PubMed ID: 12871726 [TBL] [Abstract][Full Text] [Related]
2. Differential effects of vanadate on UDP-N-acetylglucosaminyl transferase activity derived from cytosol and nucleosol. Marshall S; Okuyama R Biochem Biophys Res Commun; 2004 Jun; 318(4):911-5. PubMed ID: 15147958 [TBL] [Abstract][Full Text] [Related]
3. UDP-N-acetylglucosaminyl transferase (OGT) in brain tissue: temperature sensitivity and subcellular distribution of cytosolic and nuclear enzyme. Okuyama R; Marshall S J Neurochem; 2003 Sep; 86(5):1271-80. PubMed ID: 12911634 [TBL] [Abstract][Full Text] [Related]
4. Potential regulation of nuclear UDP-N-acetylglucosaminyl transferase (OGT) by substrate availability: ability of chromatin protein to bind UDP-N-acetylglucosamine and reduce OGT-mediated O-Linked glycosylation. Okuyama R; Marshall S Biol Pharm Bull; 2004 Aug; 27(8):1293-6. PubMed ID: 15305040 [TBL] [Abstract][Full Text] [Related]
5. Amplification of recombinant adenoviral transgene products occurs by inhibition of histone deacetylase. Dion LD; Goldsmith KT; Tang DC; Engler JA; Yoshida M; Garver RI Virology; 1997 May; 231(2):201-9. PubMed ID: 9168882 [TBL] [Abstract][Full Text] [Related]
6. Regulation of a cytosolic and nuclear O-GlcNAc transferase. Role of the tetratricopeptide repeats. Kreppel LK; Hart GW J Biol Chem; 1999 Nov; 274(45):32015-22. PubMed ID: 10542233 [TBL] [Abstract][Full Text] [Related]
7. Measurement of UDP-N-acetylglucosaminyl transferase (OGT) in brain cytosol and characterization of anti-OGT antibodies. Marshall S; Duong T; Orbus RJ; Rumberger JM; Okuyama R Anal Biochem; 2003 Mar; 314(2):169-79. PubMed ID: 12654302 [TBL] [Abstract][Full Text] [Related]
8. Turnover and characterization of UDP-N-acetylglucosaminyl transferase in a stably transfected HeLa cell line. Marshall S; Okuyama R; Rumberger JM Biochem Biophys Res Commun; 2005 Jun; 332(1):263-70. PubMed ID: 15896326 [TBL] [Abstract][Full Text] [Related]
9. Suppression of caspase-11 expression by histone deacetylase inhibitors. Heo H; Yoo L; Shin KS; Kang SJ Biochem Biophys Res Commun; 2009 Jan; 378(1):79-83. PubMed ID: 19013432 [TBL] [Abstract][Full Text] [Related]
10. Scriptaid and suberoylanilide hydroxamic acid are histone deacetylase inhibitors with potent anti-Toxoplasma gondii activity in vitro. Strobl JS; Cassell M; Mitchell SM; Reilly CM; Lindsay DS J Parasitol; 2007 Jun; 93(3):694-700. PubMed ID: 17626366 [TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells. Sonnemann J; Kumar KS; Heesch S; Müller C; Hartwig C; Maass M; Bader P; Beck JF Int J Oncol; 2006 Mar; 28(3):755-66. PubMed ID: 16465382 [TBL] [Abstract][Full Text] [Related]
12. A small molecule that inhibits OGT activity in cells. Ortiz-Meoz RF; Jiang J; Lazarus MB; Orman M; Janetzko J; Fan C; Duveau DY; Tan ZW; Thomas CJ; Walker S ACS Chem Biol; 2015 Jun; 10(6):1392-7. PubMed ID: 25751766 [TBL] [Abstract][Full Text] [Related]
14. Activation of the gamma-glutamyltransferase promoter 2 in the rat colon carcinoma cell line CC531 by histone deacetylase inhibitors is mediated through the Sp1 binding motif. Mikkelsen IM; Huseby NE; Visvikis A; Moens U Biochem Pharmacol; 2002 Jul; 64(2):307-15. PubMed ID: 12123752 [TBL] [Abstract][Full Text] [Related]
16. Possible mechanism of action of the histone deacetylase inhibitors for the induction of differentiation of HL-60 clone 15 cells into eosinophils. Ishihara K; Hong J; Zee O; Ohuchi K Br J Pharmacol; 2004 Jul; 142(6):1020-30. PubMed ID: 15210580 [TBL] [Abstract][Full Text] [Related]
17. Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors. McBain JA; Eastman A; Nobel CS; Mueller GC Biochem Pharmacol; 1997 May; 53(9):1357-68. PubMed ID: 9214697 [TBL] [Abstract][Full Text] [Related]
18. Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression. Siavoshian S; Segain JP; Kornprobst M; Bonnet C; Cherbut C; Galmiche JP; Blottière HM Gut; 2000 Apr; 46(4):507-14. PubMed ID: 10716680 [TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells. Alao JP; Stavropoulou AV; Lam EW; Coombes RC; Vigushin DM Mol Cancer; 2006 Feb; 5():8. PubMed ID: 16504004 [TBL] [Abstract][Full Text] [Related]
20. Apoptotic and autophagic cell death induced by histone deacetylase inhibitors. Shao Y; Gao Z; Marks PA; Jiang X Proc Natl Acad Sci U S A; 2004 Dec; 101(52):18030-5. PubMed ID: 15596714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]